JPRN-UMIN000047449
Recruiting
未知
evaluation of ventilation distribution during stepwise recruitment maneuver and decremental PEEP trial using electrical impedance tomography - Optimal PEEP selected by SRM and EIT
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- mechanically ventilated patients with respiratory failure
- Sponsor
- Showa University
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)no indication of mechanical ventilation 2\)hemodynamically unstable with mean blood pressure less than 55 mmHg 3\)Not suitable for EIT attachment 4\)patients with medical history of pneumothorax
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Etude de phase II ouverte évaluant en fonction du polymorphisme du CYP2D6, le taux de réponse biologique au traitement par tamoxifène (TAM) administré en situation pré-opératoire chez des patientes présentant un cancer du sein non métastatique RH+ - TAMEUCTR2008-007652-10-FRCentre René Gauducheau
Completed
Phase 4
The onset of action and safety of Dyston in glabellar lines improvementIRCT20180515039672N3Imen Vaccine Alborz184
Completed
Phase 1
Chloroquine effects on Plasmodium vivax isolate HMPBS02-PvMalaria infectionInfection - Studies of infection and infectious agentsACTRN12616000174482QIMR Berghofer Medical Research Institute24
Active, not recruiting
Not Applicable
Phase I Study to Determine the Maximum Tolerated Dose of NC-6004 in Patients with Solid Tumours - Phase I dose-escalation Study of NC-6001 in patients with solid tumoursHistologically-confirmed advanced solid tumours for which no standard therapy exists or has failed therapyEUCTR2005-004827-20-GBanoCarrier Co., Ltd.30
Recruiting
Not Applicable
Phase 1 study to determine the maximum tolerated dose and to assess the safety, pharmacokinetics, and efficacy of AVI-3207 Inj. in patients with neovascular age-related macular degeneratioDiseases of the eye and adnexaKCT0004887Avixgen9